Home LiteratureArticle Details
PMID: 17876331 Published · ppublish English Comparative Study Journal Article

Socioeconomic inequalities in cancer survival in Scotland 1986-2000.

British journal of cancer ·Vol. 97 ·No. 7 ·2007-10-08 ·Pages 999-1004

Shack LG, Rachet B, Brewster DH, Coleman MP

Abstract

We analysed trends in 5-year survival of the 18 commonest cancers in Scotland diagnosed between 1986 and 2000 and followed up to 2004 in each of five deprivation groups based on patients postcode of residence at diagnosis. We estimated relative survival up to 5 years after diagnosis, adjusting for the different background mortality in each deprivation group by age, sex and calendar period. We estimated trends in overall survival and in the deprivation gap in survival up to 2004. Five-year survival improved for all malignancies except bladder cancer and was associated with a widening in the deprivation gap in survival. For 25 of 30 cancer-sex combinations examined, 5-year survival was lower among more deprived patients diagnosed during 1996-2000, and the deprivation gap in survival had widened since 1986-1990 for 15 of these 25 cancers, similar to the trends seen in England and Wales.

MeSH Terms
Age Distribution England/epidemiology Female Humans Male Neoplasms/mortality Scotland/epidemiology Sex Distribution Socioeconomic Factors Survival Rate
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Shack L G
Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. lorraine.shack@mccr.nhs.uk
Rachet B
Brewster D H
Coleman M P
References (37)
37 references, click to expand
  1. Calculation of survival rates for cancer.
    Proc Staff Meet Mayo Clin. 1950 May 24;25(11):270-86 PMID: 15417650
  2. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival.
    Am J Public Health. 2004 Dec;94(12):2104-11 PMID: 15569961
  3. Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994).
    Eur J Cancer. 2005 Feb;41(3):411-5 PMID: 15691641
  4. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival.
    Br J Cancer. 2005 Apr 11;92(7):1279-82 PMID: 15798765
  5. Time trends in the treatment and survival of recurrences from colorectal cancer.
    Ann Oncol. 2005 May;16(5):756-61 PMID: 15790673
  6. A population-based study from New South Wales, Australia 1996-2001: area variation in survival from colorectal cancer.
    Eur J Cancer. 2005 Nov;41(17):2715-21 PMID: 16230004
  7. Origins of socio-economic inequalities in cancer survival: a review.
    Ann Oncol. 2006 Jan;17(1):5-19 PMID: 16143594
  8. Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK.
    J Epidemiol Community Health. 2006 Mar;60(3):208-12 PMID: 16476749
  9. Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing.
    Br J Cancer. 2006 Aug 7;95(3):398-400 PMID: 16832416
  10. Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia.
    Br J Cancer. 2006 Aug 7;95(3):401-5 PMID: 16832417
  11. Explaining inequalities in access to treatment in lung cancer.
    J Eval Clin Pract. 2006 Oct;12(5):573-82 PMID: 16987120
  12. Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study.
    Breast Cancer Res Treat. 2007 Nov;105(3):369-75 PMID: 17211536
  13. Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies.
    BMJ. 2001 Apr 7;322(7290):830-1 PMID: 11290637
  14. Rising incidence of prostate cancer in Scotland: increased risk or increased detection?
    BJU Int. 2000 Mar;85(4):463-72; discussion 472-3 PMID: 10691826
  15. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.
    BJU Int. 2000 Jun;85(9):1058-62 PMID: 10848694
  16. Comparison of various characteristics of women who do and do not attend for breast cancer screening.
    Breast Cancer Res. 2002;4(1):R1 PMID: 11879559
  17. Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer.
    Br J Surg. 2002 May;89(5):586-90 PMID: 11972548
  18. Colon cancer in France: evidence for improvement in management and survival.
    Gut. 2002 Jul;51(1):60-4 PMID: 12077093
  19. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    J Natl Cancer Inst. 2002 Jul 3;94(13):981-90 PMID: 12096083
  20. Impact of deprivation and rural residence on treatment of colorectal and lung cancer.
    Br J Cancer. 2002 Sep 9;87(6):585-90 PMID: 12237766
  21. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study.
    Lancet. 2002 Aug 24;360(9333):587-91 PMID: 12241928
  22. Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival.
    J Epidemiol Community Health. 2003 Apr;57(4):301-9 PMID: 12646548
  23. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
    Ann Oncol. 2003;14 Suppl 5:v128-49 PMID: 14684503
  24. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.
    Br J Cancer. 2004 Apr 5;90(7):1367-73 PMID: 15054456
  25. Cancer disparities by race/ethnicity and socioeconomic status.
    CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93 PMID: 15061598
  26. Individual and regional determinants of mammography uptake.
    Can J Public Health. 2004 Jul-Aug;95(4):290-4 PMID: 15362474
  27. Analysis of categorical data by linear models.
    Biometrics. 1969 Sep;25(3):489-504 PMID: 5824401
  28. Relative survival and the estimation of net survival: elements for further discussion.
    Stat Med. 1990 May;9(5):529-38 PMID: 2349404
  29. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
    JAMA. 1994 Aug 17;272(7):530-4 PMID: 8046807
  30. Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989.
    Cancer. 1995 Jun 15;75(12):2946-53 PMID: 7773946
  31. Deprivation, stage at diagnosis and cancer survival.
    Int J Cancer. 1995 Nov 3;63(3):324-9 PMID: 7591225
  32. Deprivation indices: their interpretation and use in relation to health.
    J Epidemiol Community Health. 1995 Dec;49 Suppl 2:S3-8 PMID: 8594130
  33. Socioeconomic status and cancer survival in Ontario.
    J Clin Oncol. 1997 Apr;15(4):1680-9 PMID: 9193369
  34. Socioeconomic status and comorbidity among newly diagnosed cancer patients.
    Cancer. 1997 Oct 15;80(8):1482-8 PMID: 9338473
  35. Socioeconomic differences in cancer survival: a review of the evidence.
    IARC Sci Publ. 1997;(138):177-206 PMID: 9353665
  36. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
    BMJ. 1997 Nov 1;315(7116):1117-21 PMID: 9374883
  37. Socioeconomic status and stage at presentation of colorectal cancer.
    Lancet. 1998 Oct 31;352(9138):1439 PMID: 9807992
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
DOI
10.1038/sj.bjc.6603980
Email
lorraine.shack@mccr.nhs.uk
Published
2007-10-08
Epub
2007-00-18
Pages
999-1004
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2360415
Subset
IM
External Links
PubMed source DOI: 10.1038/sj.bjc.6603980 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2